EP. 7: Evolving Treatment Strategies in Early HER2+ Breast Cancer
Published: March 20th 2025 | Updated: March 20th 2025Experts discuss how, nearly half of patients diagnoses with HER-2 positive metastatic brain cancer do develop brain metastasis. It is thought that larger molecule treatments such as the monoclonal antibodies likely do not cross an intact blood brain barrier which is often why patients develop brain metastases
EP. 9: Treatment Selection, Sequencing, and Supportive Care for Brain Metastases in HER2+ mBC
March 28th 2025Experts discuss how, it is crucial to approach treatment strategies with both compassion and transparency. It is important to explain the complexity of the situation and maintain clear and accessible language when discussing treatment strategies with patients and their families.